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Abstract 
Food induced sensitization has been report-
ed in pediatric liver recipients. However long
term follow up has not been established so far.
We report here our experience regarding 3
pediatric patients who developed acquired food
allergy  after  liver  transplantation.  The  first
patient suffered from persistent diarrhea and
eczema.  The  second  one  presented  with
abdominal  pain  with  no  signs  of  rejection,
abdominal discomfort, vomiting when ingest-
ing milk proteins and responded well to the
elimination diet. The third patient presented
with  facial  angioedema  and  hoarseness  of
voice.  She  had  multiple  food  allergies  and
reacted  to  milk,  egg  and  sesame.  All  the
patients had elevated total Immunoglobulin E
(IgE) and elevated specific IgE antibodies to
the implicated food allergens. The first patient
presented  clinical  manifestations  of  allergy
when  she  was  19  months  old.  The  second
patient became allergic at the age of 16 and the
third patient at the age of 3. The symptoms of
food allergy persisted for 8 years in the first
case and for 2 years in the other two cases.
Low  levels  of  specific  IgE antibodies  to  the
implicated food allergens and an enhanced T-
helper 1 cell immune response toward interfer-
on-gamma production were markers of toler-
ance acquisition. The long term prognosis in
our cases was excellent. Food allergy resolved
in all the patients. The long term prognosis of
acquired  food  allergy  after  liver  transplanta-
tion is currently obscure. More studies would
be  needed  including  greater  number  of
patients to determine whether acquired food
allergy is transient in pediatric liver recipients.
Introduction
Food induced sensitization to various food
allergens has been reported in pediatric liver
recipients  after  orthotopic  liver  transplanta-
tion. The increased prevalence of food allergy
was  noted  in  tacrolimus-immunosuppressed
pediatric liver recipients ranging from 10% to
17%.1 Post-Transplant  Food  Allergy  (PTFA)
although ascribed to tacrolimus treatment by
various  authors  tacrolimus  treatment  alone
cannot  account  for  the  development  of  food
allergy after liver transplantation. In adults the
only cases of post-transplant sensitization to
food allergens have occurred via passive trans-
fer from food allergic donor.2
The phenomenon is consistent with previ-
ous findings of allergy transfer via bone mar-
row transplantation and the finding that donor
derived stem cells present in a liver graft can
sustain long-term hematopoiesis in a recipi-
ent.3,4 However, the development of a new food
allergy  after  liver  transplantation  has  been
reported in children receiving liver grafts from
donors with no known food allergy.2
We  present  three  out  of  twenty  pediatric
liver  recipients  followed  in  our  center  who
developed  food  allergy  after  receiving  liver
transplants from donors with no documented
history of food allergy. Possible mechanisms
underlying  the  development  of  food  allergy
after transplantation are discussed. Long term
follow up in all three cases has provided evi-
dence on the prognosis of PTFA.
Case #1
The  case  involves  a  10-year-old  girl  who
underwent  orthotopic  liver  transplantation
(OLT)  for  extrahepatic  biliary  atresia  at  7
months of age. The child has a positive family
history of atopy as her mother has asthma. The
transplant was from a deceased donor with no
history  of  atopy.  Her  post  operative  growth
improved  satisfactorily.  The  child’s  weight
ascended from the 9th percentile before opera-
tion to the 25th percentile, while her height
remained on the 25th percentile. Methylpred-
nisolone, azathioprine and tacrolimus immu-
nosuppression were initially used. Tacrolimus
therapy  was  continued  at  a  dose  of  0.5-
3mg/Kg/day  achieving  a  serum  level  of  2-10
ng/mL.
Prior to transplantation the child followed
an unrestricted diet with no history of adverse
food reaction. Twelve months after OLT, she
presented mucoid bloody stools. Her laboratory
investigation  revealed  leukocyte  count  of
9.3ﾥ103/mm3, with 41% neutrophils, 42% lym-
phocytes, 7.5% monocytes and 5% eosinophils
(normal <6 %). The ESR was 5 mm/h. The total
IgE was  29  UI/mL  (normal  range:0-50).  Her
platelet count was normal. The liver enzymes
were not elevated and the prothrombin time
(PT) and the Activated Partial Thromboplastin
Time (PTT) were not prolonged. The liver biop-
sy showed perivenular drop out but no rejec-
tion. Between the 12th till the 18th months after
liver transplantation the child received month-
ly hospital admissions due to persistent symp-
toms. Each time the child was not febrile and
the  investigation  for  viral  enteropathogens,
such  as  rotavirus,  enteric  adenovirus,
cytomegalovirus and herpes simplex virus, was
negative. Stool cultures for bacterial and para-
sitic  enteropathogens  were  also  negative.
Management was with oral rehydration and a 7
day course of Trimethoprim/Sulfamethoxazole
(TMP/SMX) per os 6 mg/Kgr BW/24h divided in
two daily doses as prophylactic treatment, due
to  immunosuppression.  At  the  age  of  26th
months  -  19th month  after  liver  transplanta-
tion-  on  admission  due  to  persistent  symp-
toms, her blood count revealed 6.3ﾥ103 leuko-
cytes with 50% neutrophils, 29% lymphocytes
and  12%  eosinophils  (756/mm3 absolute
count). On clinical examination eczema was
noted. She underwent allergological investiga-
tion which showed elevated total serum levels
of Immunoglobulin E (IgE) of 99 UI/mL (nor-
mal range 0-50) and specific IgE antibodies to
alpha-lactalbumin  and  beta-lactoglobulin  of
3.58 UI/mL and 16.34 UI/mL respectively (neg-
ative <0.35). Specific IgE to egg, soy, gluten,
fish,  house  dust  mites,  grasses  and  moulds
were absent. The results of the skin prick tests
were  parallel  to  those  of  specific  IgE.  The
mother was then instructed to start a diet free
of cow’s milk protein and substitute milk with
an extensively hydrolyzed milk formula. On fol-
low-up her eczema deteriorated and the moth-
er  reported  sporadic  episodes  of  diarrhea.
Laboratory findings included a leukocyte count
of  7.4ﾥ103 with  24%  eosinophils  (normal
<6%),  normal  liver  function  tests,  and
tacrolimus  blood  levels  of  6.9  ng/mL.  The
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patient was closely monitored for milk protein
avoidance and was started on an elementary
milk substitute formula with marked and rapid
improvement of symptoms. The following four
days, eosinophils decreased to normal values.
Careful  interview  showed  that  the  child’s
mother hadn’t introduced a strict milk protein
avoidance diet and the child had ingested sev-
eral milk containing foods and dairy products.
At the age of 9.5 years cytokine assessment
revealed a cytokine production toward T-helper
2 cell (Th2) immune response characterized
by elevated levels of interleukin 4 (IL-4) and
(interleukin 13) IL-13, normal (interleukin 5)
IL-5 and  slightly  elevated  interferon-gamma
(IFN-γ). Determination of specific IgEantibod-
ies to milk proteins showed that they were still
moderately elevated. The regulatory cytokines
(interleukin  10)  IL-10 and  the  transforming
growth factor-beta (TGF-β) were also elevated
(Table 1). Six months later reassessment of
specific IgEantibodies to milk proteins showed
that the titers were negative. She received hos-
pital  admission  and  she  underwent  a  milk
challenge test which was negative. She has not
been  avoiding  milk  and  dairy  products  ever
since.
Case #2
Is an 18-year-old boy who received a liver
graft at 6 months of age due to extra-hepatic
biliary  atresia.  The  deceased  donor  had  no
known history of atopy. The patient had been
receiving orally an immunosuppressive regi-
men of cyclosporin 2-6 mg/Kgr/day and methyl-
prednisolone at 0.1 mg/Kg/day before he was
switched to tacrolimus at 0.15-0.3 mg/Kg/day
achieving a serum level of 3 ng/mL - 9.2 ng/mL
and  methylprednisolone.  The  child  and  his
family had no history of any allergic disease.
After transplantation the patient followed an
unrestricted diet without any signs of adverse
reactions  to  foods.  Patient’s  post-operative
course was uneventful. On follow ups his liver
enzymes were normal and liver biopsies per-
formed every 3 years have not shown signs of
rejection.
At  the  age  of  16  years  the  patient  com-
plained of abdominal pain and discomfort and
occasionally nausea and vomiting after ingest-
ing milk and dairy products. On clinical exam-
ination no hives or eczema was present. His
abdominal ultrasound showed a normal liver
structure  and  the  Doppler  ultrasonography
showed unrestricted blood flow in the hepatic
artery and portal vein. Laboratory investigation
showed not elevated liver enzymes and normal
PT and PTT values. He revealed total serum IgE
of  250  UI/mL  (normal  range  0-100)  without
eosinophilia,  as  the  absolute  count  was
117/mm3 (normal <500/mm3) and specific IgE
antibodies  to  milk  of  3.78  UI/mL  (negative
<0.35). He was placed on a milk elimination
diet with complete resolution of his symptoms.
Two years later at the age of 18 the level of spe-
cific  IgE antibodies  to  cow’s  milk  were  0.78
UI/mL. A moderate amount of cow’s milk pro-
tein  was  reintroduced  in  the  patient’s  diet
without  reoccurrence  of  his  previous  symp-
toms.
Assessment of cytokine production showed
an  enhanced  T-helper  1  cell  (Th1)  immune
response,  as  IFN-γ was  moderately  elevated
without accompanying downregulation of Th2
cytokines, as IL-4 and IL-13 were elevated at
the  time  when  cow’s  milk  allergy  diagnosis
was established. The regulatory cytokine TGF-
β was within the normal range (Table 1).
Case #3
The  third  case  involves  a  12-year-old  girl
who  underwent  OLT  for  extrahepatic  biliary
atresia at 8 months of age. The living donor
was her mother who had no personal or family
history  of  atopy.  The  patient  has  been  on
tacrolimus  immunosuppression  for  the  last
eleven  years  achieving  a  serum  level  of  4
ng/mL. She experienced the first allergic reac-
tion almost 2 years after transplantation when
she was about 3 years old. When she ingested
a piece of candy made of sesame seeds she
presented with lip swelling, facial angioedema
and  hoarseness  of  voice.  She  was  managed
with  intramuscular  Adrenalin  injection  and
corticosteroids. She has been avoiding sesame
and  no  accidental  exposures  occurred  ever
since. The child presented similar symptoms
when she was drinking milk or when ingesting
dairy  products,  white  fish  and  egg  proteins.
Detection of specific IgE antibodies to various
foods showed by the age of 3 years elevated lev-
els  of  specific  IgE antibodies  to  milk,  egg,
white fish, pork and chicken.
At the age of 5 years the level of specific IgE
antibodies to cow’s milk decreased significant-
ly at the level of 0.78 UI/mL and she has been
able to tolerate milk ever since. At the age of 11
years she started to tolerate well cooked egg
but she was still unable to tolerate raw egg.
Total serum IgE was at the level of 992 UI/mL
and  the  absolute  eosinophil  count  was
195/mm3 (normal<500 /mm3). In spite of the
moderately elevated specific IgE antibodies to
pork and chicken the patient has always been
able to tolerate them and her diet in regards to
pork and chicken has never been restricted.
Cytokine assessment showed increased lev-
els  of  the  regulatory  cytokine  TGF-β,  an
enhanced Th1 immune response toward IFN-γ
production and normal Th2cytokines (Table 1).
Conclusively,  sensitization  to  milk  protein
in our cases occurred in children who received
liver grafts from donors with no known history
of food allergy. The long term follow up was 9.5
years in the first case, 17.5 years in the second
case and 11 years in the third case. Food aller-
gy diagnosis was established in all the patients
by  assessing  the  specific  IgE antibodies  to
common food allergens and by evaluating the
patient for resolution of the allergic symptoms.
Eosinophilia was present in only one patient
who had a persistent allergy to cow’s milk pro-
tein  which  resolved  after  eight  years.  The
onset  of  allergy  became  evident  when  the
patient was 19 months old in the first case and
16 years old and 3 years old in the second and
third case respectively. The duration of symp-
toms was 8 years in the first case and 2 years
in the other two cases. All the patients had an
enhanced  Th1 dominant  immune  response
before achieving tolerance. High total serum
IgE, elevated specific IgE antibodies to various
food  allergens  and  the  use  of  tacrolimus  as
immunosuppressive regimen was a common
feature in all our cases. 
Discussion
Type  I  allergic  reactions  to  common  food
allergens have increasingly been reported in
transplant  recipients,  mainly  in  orthotopic
liver transplanted children.2,5-11 The transfer of
allergy from a food allergic liver donor to a pre-
viously non allergic liver transplant recipient
was first reported in 1997.6 The only reports of
acquired food allergy in adults after liver trans-
Case Report
Table1. Cytokine assessment in the 3 pediatric cases.
Cytokine  Case #1 (age 9.5) Case #2 (age 16) Case #3 (age 12)
concentration (pg/mL)
IL-2 7.8 normal <46 9 normal <48 14 normal <46
INF-γ 18 ₑnormal <11 20 ₑnormal <16 17 ₑnormal (3-16)
IL-4 54 ₑnormal <13 100 ₑnormal <45 28 normal (0-45)
IL-13 17 normal <23 20 normal <60 7.7 normal <23
IL-10 14 ₑnormal <4 21 ₑnormal <10 9.1 ₑnormal <4
TFG-β 20 ₑnormal <13 19 normal <20 18 ₑnormal (0-10)
IL, interleukin; INF-γ, interferon-gamma; TFG-β, transforming growth factor-ʲ.[Pediatric Reports 2012; 4:e6] [page 19]
plantation have occurred via passive transfer
from  food  allergic  liver  donor,  whereas
acquired  food  allergy  after  liver  transplanta-
tion  has  been  widely  reported  in  children
receiving liver transplants from donors with no
known food allergy. 
Tacrolimus  mechanism  of  action  involves
the  inhibition  of  a  protein  phoshatase,  cal-
cineurin,  which  results  in  repression  of  an
early  step  of  T  cell  activation.  Although  its
administration usually produces a therapeutic
immunosupression, a paradoxical elevation of
total serum IgEwas observed in these patients.
Another explanation could be that the trans-
planted liver retains sufficient allergen specif-
ic IgE in its large vascular pool to sensitize the
recipient’s mast cells. Although IgE circulates
in the peripheral blood for only a few days, it
remains bound to high affinity receptors on
tissue mast cells for several months. However,
the transplanted liver contains not just donor T
and B lymphocytes, but also dendritic cells and
pluripotential hematopoietic stem cells capa-
ble of surviving for several months after liver
transplantation.  These  cells  could  possibly
migrate to the recipient’s lymphoid organs or
other sites and there provoke recipient sensiti-
zation.12
Eosinophilia was present in one of the three
patients receiving tacrolimus immunosupres-
sion  the  other  two  patients  had  normal
eosinophil  count  while  peripheral  blood
eosinophilia has been frequently observed in
patients with post-transplant food allergy. The
high prevalence of eosinophilia in tacrolimus
treated patients supports the hypothesis that
the cases of new onset food allergy are a result
of  calcineurin  inhibitor  imbalance  between
Th1 and Th2 helper cells and not a result of
passive  transfer  of  sensitized  donor  lymho-
cytes in the transplanted organ.13 Tacrolimus
binds to immunophilins (proteins that bind to
immunosuppressive  drugs)  termed  FKBP-FK
binding proteins. This complex then binds to
and inhibits the activity of calcineurin, a ser-
ine threonine phosphatase that plays a critical
role in interleukin 2 (IL-2) promoter induction
during T-cell activation.14
The  immunological  investigation  by
cytokine  assessment  showed  that  a  Th1
immune response toward IFN-γ was present in
all patients. The first two patients showed a
Th2 cytokine dominance characterized by ele-
vated IL-4, while the third patient revealed a
normal serum IL-4 level when she became tol-
erant to various food allergens. The regulatory
cytokine TGF-β was elevated in the first case
shortly before the patient became tolerant to
cow’s milk proteins and also in the third case
when the patient outgrew her allergy (Table 1).
The  mechanism  of  tolerance  to  food  is  not
completely understood. It is suspected that T-
regulatory  cells  are  involved  in  tolerance
acquisition. The hypothesis for a key tolero-
genic role of regulatory T-cells has been rein-
forced by studies showing that children having
outgrown  food  allergy  with  mostly  gastroen-
terologic symptoms, have increased number of
CD4+CD25+ T-regulatory  cells  in  their  gut
mucosa. Regulatory T lymphocytes will secrete
IL-10 and TGF-β which may downregulate the
IgE-driven reactions. Promoting the IL-10 rich
environments in the gut seems to be an option
to prevent or even treat food allergy.15 The reg-
ulatory cytokine TGF-β was an early marker of
tolerance acquisition in the two patients. 
The first patient who had a positive family
history of atopy and eosinophilia suffered from
persistent  food  allergy,  while  the  other  two
patients who had normal eosinophil count in
the peripheral blood and a negative family his-
tory of atopy suffered from a more transient
type of food allergy. Factors such as peripheral
eosinophilia and a positive family history of
atopy were related to persistent PTFA in our
patients. 
In the second case the onset of food allergy
was delayed .The diagnosis in this case was
based on the patient’s gastrointestinal symp-
toms, the exclusion of other diagnosis and by
taking into account the elevated level of the
specific IgE antibodies to milk proteins. The
diagnosis was supported by the resolution of
the patient’s symptoms when a milk protein
elimination diet was introduced. Achievement
of tolerance was determined by assessing the
levels of specific IgE antibodies to milk pro-
teins.  Although  a  proper  challenge  has  not
been carried out, when the level of specific IgE
antibodies to milk proteins became negative,
the  patient’s  diet  relaxed  with  no  adverse
events. The level of the specific IgE antibodies
to food proteins proved to be a useful marker
for monitoring food allergy in all our cases.
Low levels of specific IgE antibodies to the pre-
viously implicated food proteins were related
to a successful reintroduction of the foods in
the patient’s diets.
Transplant acquired food allergies are not
uncommon in pediatric liver recipients.2,10,13-
14,16-20 Health providers should have increased
suspicion of the complication in liver trans-
planted children in order to make an appropri-
ate investigation and follow up. The long term
prognosis of acquired food allergy in pediatric
liver recipients is currently obscure. A letter to
the  editor  of  JACI  2008  by  Frischmeyer-
Guerrerio P, et al.21 reports that 23 out of 25
children followed given diagnosis of food aller-
gy after organ transplantation were able to fol-
low unrestricted diets after a median duration
of 2.4 years follow up in the clinic and 6.1 year
by telephone. Maarof et al.22 in 2011 reported
that IgE-mediated multiple food allergy after
liver transplantation could be efficiently man-
aged  after  switch  from  tacrolimus  to
cyclosporine  immunosuppressive  regimen
with  an  elimination  diet.  The  prognosis  of
PTFA of the 3 patients followed in our clinic so
far  has  been  excellent.  All  our  patients
remained  on  tacrolimus  immunosupression.
They were all placed on elimination diets of
the  offending  food  allergens  and  they  all
achieved tolerance after a long term follow up.
The onset of allergic reactions to cow’s milk
protein was 19 months old,16 years old and 3
years old in cases 1.2 and 3 respectively. Cow’s
milk allergy persisted for 8 years in the first
case and for 2 years in the other two cases.
Development of food tolerance in patients
with acquired food allergies after a liver trans-
plant remains an important issue. The patients
themselves  and  health  care  providers  often
report that restricted diets have a significant
impact  on  their  quality  of  life.  Families  of
transplanted patients with acquired food aller-
gies  always  address  questions  to  physicians
who provide follow up in regards to food toler-
ance acquisition. The prognosis of PTFA has
not been well established so far. Only limited
data are available in regards to the prognosis
of  PTFA  and  more  studies  including  greater
number of patients are required in order to
establish the long term outcome of PTFA in
pediatric liver recipients. 
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